glp-1 gip therapy effectiveness muscle preservation Protection Guide Optimizing GLP-1 therapies for obesity
Description
The synergy between the two receptor pathways is present even at low doses, which is an argument for tirzepatide-based microdosing over semaglutide-based microdosing from a metabolic standpoint
Will definitely use again
Be proactive in guiding your patients through this process
It keeps you fuller longer, helps preserve lean muscle mass and requires more calories to digest than carbs or fats
Lancet Diabetes Endocrinol 4(6):537547
